Photocure granted patent in Europe and Russia for Visonac in the treatment of acne
"We are very pleased with these decisions giving a strong patent protection on Photocure's lead dermatology product", says Kjetil Hestdal, President and CEO of Photocure. "Patent protection of our products is key to succeed in the market".
VisonacTM is a photodynamic therapy that combines the VisonacTM cream with illumination by a red light source to treat acne. Visonac(TM) cream contains MAL. The cream is applied to the acne area to be treated and after a short incubation time, the skin is illuminated with red light. The PDT procedure kills bacteria and appears to have a beneficial effect on sebaceous glands and inflammatory cells.
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.